Xenon Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Burnaby
XENE chart
What traders are saying about $XENE
Latest postsXenon Pharmaceuticals Inc. news
- Precision Trading with Xenon Pharmaceuticals Inc. (XENE) Risk Zones
Stock Traders Daily ·
- Form 4 Xenon Pharmaceuticals Inc.: Ian Mortimer (Director, PRESIDENT & CEO) For: 30 September
Investing.com UK ·
- Xenon Pharmaceuticals Inc. (XENE) stock price, news, quote and history
Yahoo Finance Singapore ·
- Xenon Pharmaceuticals Inc. Estimates – NASDAQ:XENE
TradingView ·
- Law firm investigates Xenon Pharmaceuticals aft...
Pluang ·
- Wolf Popper LLP Continues Investigation on Behalf of Xenon Pharmaceuticals Inc. Investors
GlobeNewswire ·
- Inside the $1 Billion Blockbuster Opportunity Sending Rapport Therapeutics Stock Higher
Yahoo Finance ·
- XENE's Depression Trial Setback: Is Its Pipeline Still Attractive?
Yahoo Finance ·
- Why Xenon Pharmaceuticals (XENE) Is Getting Attention Now
Yahoo Finance ·
- Xenon Pharmaceuticals (XENE) Stock May Still Look Above Fair Value On Its Research Pipeline
Yahoo Finance ·
- Insiders Are Buying These 2 ‘Strong Buy’ Stocks With Over 60% Upside
Yahoo Finance ·
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Xenon Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$345.9M | -$234.3M | -$182.4M | -$125.4M |
| Diluted EPS | $-4.36 | $-3.01 | $-2.73 | $-2.06 |
| Total assets (year end) | $633.2M | $798.1M | $964.8M | $754.1M |
| Cash and equivalents (year end) | $199.2M | $142.7M | $148.6M | $57.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Xenon Pharmaceuticals Inc.
- Ticker
- XENE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Burnaby
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1582313
Frequently asked questions
What exchange is Xenon Pharmaceuticals Inc. listed on?
Xenon Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol XENE.
What industry is Xenon Pharmaceuticals Inc. in?
Xenon Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Xenon Pharmaceuticals Inc. headquartered?
Xenon Pharmaceuticals Inc.'s business address on file with the SEC is in Burnaby.
When does Xenon Pharmaceuticals Inc.'s fiscal year end?
Xenon Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Xenon Pharmaceuticals Inc. report?
Xenon Pharmaceuticals Inc. reported $311,000 in revenue for calendar year 2017, according to its SEC filings.